Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Affinivax Inc (Affinivax), a subsidiary of GSK plc, is a biopharmaceutical company that develops vaccines for infectious and immune-mediated diseases. It is investigating its lead vaccine candidate, AFX3772 to protect against streptococcus pneumoniae infections; and ASP1004 to prevent klebsiella pneumoniae and pseudomonas aeruginosa. The company is also developing vaccines targeting staphylococcus aureus and clostridium difficile bacterial infections, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and melanoma. Affinivax utilizes its proprietary multiple antigen presenting system (MAPS) platform to develop vaccines using high affinity biotin-rhizavidin binding interaction to exhibit the immunogenic epitopes of polysaccharide and protein antigens for strong immune protection. It works in collaboration with Astellas Pharma Inc, and the Bill & Melinda gates foundation to develop vaccines. Affinivax is headquartered in Cambridge, Massachusetts, the US.
Headquarters
United States of America
Address
Suite 302, 301 Binney Street, Cambridge, Massachusetts, 02142
Website
affinivax.com
Telephone
1 617 4650865
Industry
Pharmaceuticals and Healthcare
Affinivax Inc premium industry data and analytics
Products and Services
| Products |
|---|
| Pipeline: |
| AFX3772: |
| Streptococcus Pneumoniae Infections |
| XYZ |
| XYZ |
| XYZ |
Competitor Comparison
| Key Parameters | Affinivax Inc | Juvaris BioTherapeutics Inc | PaxVax Inc | Protein Sciences Corp | Vaxcyte Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Cambridge | Pleasanton | Redwood City | Meriden | San Carlos |
| State/Province | Massachusetts | California | California | Connecticut | California |
| No. of Employees | - | - | - | - | 414 |
| Entity Type | Private | Private | Private | Private | Public |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Bob More | Chairman | Executive Board | - | - |
| Steven Brugger | Director; President; Chief Executive Officer | Executive Board | - | - |
| Elizabeth Radcliffe | Chief Financial Officer | Senior Management | 2021 | - |
| Vanya Sagar | Chief People Officer | Senior Management | 2021 | - |
| Kara Bickham, MD | Chief Medical Officer | Senior Management | 2021 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer